Andina Acquisition Corp III (OQ:ANDA)

Nov 04, 2020 10:45 am ET
Andina Acquisition Corp. III and EMMAC Life Sciences Limited Announce Termination of Negotiations
Andina Acquisition Corp. III (NASDAQ: ANDA, ANDAW, and ANDAU) (“Andina”) and EMMAC Life Sciences Limited (“EMMAC”) announce that they have today mutually terminated negotiations regarding the proposed business combination between the parties,...
Oct 28, 2020 10:45 am ET
Andina Acquisition Corp. III Announces Adjournment of the Extraordinary General Meeting of Shareholders for Approving an Extension of the Deadline Related to Consummating its Initial Business Combinat
Andina Acquisition Corp. III (NASDAQ: ANDA, ANDAW, and ANDAU) (“Andina” or the “Company”) today announced that the Company’s shareholders have voted to adjourn the meeting for the consideration of extending the date by which Andina must consummate...
Oct 28, 2020 06:00 am ET
Andina Acquisition Corp. III Announces Intention to Adjourn Extraordinary General Meeting of Shareholders for Approving an Extension of the Deadline Related to Consummating its Initial Business Combin
Andina Acquisition Corp. III (NASDAQ: ANDA, ANDAW, and ANDAU) (“Andina” or the “Company”) today announced that the Company’s board of directors has determined to postpone the vote by its shareholders on extending the date by which Andina must...
Oct 26, 2020 11:33 am ET
Andina Acquisition Corp. III and EMMAC Life Sciences Limited Provide Update on Status Towards Signing Business Combination Agreement
Andina Acquisition Corp. III (NASDAQ: ANDA, ANDAW, and ANDAU) (“Andina”) and EMMAC Life Sciences Limited (“EMMAC”) jointly provided an update regarding their continued progress towards signing a business combination agreement, pursuant to which...
Aug 18, 2020 02:00 am ET
EMMAC Life Sciences Group Secures GDP licence for Swiss pharmaceutical entity, EMMAC SAGL Approved to import, distribute and export medicinal products for domestic, EU and international markets
EMMAC Life Sciences Group (”EMMAC” or the “Group” or the “Company”), Europe’s largest independent cannabis company, is pleased to announce that EMMAC SAGL, the Group’s pharmaceutical entity in  Switzerland, has secured its Good Distribution...
Jul 28, 2020 02:00 am ET
EMMAC Life Sciences Group (”EMMAC” or the “Group” or the “Company”) Medalchemy receives licence for cultivation of medical cannabis
EMMAC Life Sciences Group, Europe’s largest independent cannabis company, is pleased to announce that Medalchemy, the Group’s Good Manufacturing Practice (“GMP”) certified manufacturing site in Alicante, Spain has secured approval from the Spanish...
Jul 24, 2020 08:31 am ET
Andina Acquisition Corp. III and EMMAC Life Sciences Limited to Host Joint Zoom Webcast and Conference Call Today at 11:00 AM to Discuss Non-Binding Letter of Intent for Business Combination
Andina Acquisition Corp. III (NASDAQ: ANDA, ANDAW, and ANDAU) (“Andina”) and EMMAC Life Sciences Limited (“EMMAC”) jointly announced that the companies will host a Zoom webcast and conference call at 11:00 AM ET today to discuss their non-binding...
Jul 22, 2020 08:30 am ET
Andina Acquisition Corp. III and EMMAC Life Sciences Limited Announce Signing of Non-Binding Letter of Intent for Business Combination
Andina Acquisition Corp. III (NASDAQ: ANDA, ANDAW, and ANDAU) (“Andina”) and EMMAC Life Sciences Limited (“EMMAC”) jointly announced today that they have signed a non-binding letter of intent (the “LOI”) relating to a business combination, pursuant...
Jan 09, 2018 12:51 pm ET
SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Andina Acquisition Corp. II, - ANDA
NEW YORK, Jan. 9, 2018 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a boutique securities firm headquartered at the Empire State Building in New York City, is investigating Andina Acquisition Corp. II, ("Andina" or the "Company") (NasdaqCM: ANDA) for possible breaches of fiduciary duty by its board of directors. ...
Oct 27, 2017 08:41 pm ET
Andina Acquisition Corp. II Announces Agreement to Acquire Lazydays R.V. Center, Inc.
Andina Acquisition Corp. II (“Andina”) (NASDAQ: ANDAU, ANDA, ANDAR, ANDAW), a special purpose acquisition company formed for the purpose of effecting a merger, acquisition or similar business combination, announced today that it has entered into a definitive agreement to acquire Tampa-based Lazydays R.V. Center, Inc. and its affiliates (“Lazydays” or the “Company”) from private investment funds managed by Wayzata Investment Partners LLC (“Wayzata) and other minority shareholders (collectively, the “Seller Group”). Total consideration to b

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please subscribe. Our packages start at $1.00 plus tax for the first month.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.